| scholarly article | Q13442814 |
| P8978 | DBLP publication ID | journals/jcisd/BeaversMSPDCHS08 |
| P356 | DOI | 10.1021/CI800085C |
| P932 | PMC publication ID | 2923042 |
| P698 | PubMed publication ID | 18598021 |
| P5875 | ResearchGate publication ID | 5255406 |
| P50 | author | Donna Huryn | Q42633709 |
| P2093 | author name string | Amos B Smith | |
| Barry S Cooperman | |||
| Scott L Diamond | |||
| Michael C Myers | |||
| Mary Pat Beavers | |||
| Parag P Shah | |||
| Jeremy E Purvis | |||
| P2860 | cites work | The Protein Data Bank | Q24515306 |
| New drugs for neglected diseases: from pipeline to patients | Q24802169 | ||
| Inhibition mechanism of cathepsin L-specific inhibitors based on the crystal structure of papain-CLIK148 complex | Q27620728 | ||
| Design of noncovalent inhibitors of human cathepsin L. From the 96-residue proregion to optimized tripeptides | Q27639963 | ||
| Crystal structure of papain-E64-c complex. Binding diversity of E64-c to papain S2 and S3 subsites | Q27642171 | ||
| Use of papain as a model for the structure-based design of cathepsin K inhibitors: crystal structures of two papain-inhibitor complexes demonstrate binding to S'-subsites | Q27765850 | ||
| On the size of the active site in proteases. I. Papain | Q27860826 | ||
| The crystal structure of human cathepsin L complexed with E-64 | Q28237390 | ||
| Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes | Q29616736 | ||
| Kinetic characterization and molecular docking of a novel, potent, and selective slow-binding inhibitor of human cathepsin L | Q33327656 | ||
| Cysteine protease inhibitors as chemotherapy for parasitic infections | Q33649956 | ||
| Cysteine proteinases and the pathogenesis of amebiasis | Q33886180 | ||
| Target-based drug discovery for malaria, leishmaniasis, and trypanosomiasis | Q33927718 | ||
| Functional expression of falcipain, a Plasmodium falciparum cysteine proteinase, supports its role as a malarial hemoglobinase. | Q35415207 | ||
| Cysteine protease inhibitors block Toxoplasma gondii microneme secretion and cell invasion | Q35635992 | ||
| Identification and synthesis of a unique thiocarbazate cathepsin L inhibitor | Q39035003 | ||
| Overexpression of cruzipain, the major cysteine proteinase of Trypanosoma cruzi, is associated with enhanced metacyclogenesis | Q39528071 | ||
| Identification of Leishmania major cysteine proteinases as targets of the immune response in humans | Q43545550 | ||
| Aziridine-2,3-dicarboxylate inhibitors targeting the major cysteine protease of Trypanosoma brucei as lead trypanocidal agents | Q46974998 | ||
| Aziridide-Based Inhibitors of Cathepsin L: Synthesis, Inhibition Activity, and Docking Studies | Q61066429 | ||
| Structure based development of novel specific inhibitors for cathepsin L and cathepsin S in vitro and in vivo | Q73077056 | ||
| P433 | issue | 7 | |
| P304 | page(s) | 1464-1472 | |
| P577 | publication date | 2008-07-04 | |
| P1433 | published in | Journal of Chemical Information and Modeling | Q3007982 |
| P1476 | title | Molecular docking of cathepsin L inhibitors in the binding site of papain | |
| P478 | volume | 48 |
| Q89634052 | A Review of Small Molecule Inhibitors and Functional Probes of Human Cathepsin L |
| Q34051627 | A small-molecule oxocarbazate inhibitor of human cathepsin L blocks severe acute respiratory syndrome and ebola pseudotype virus infection into human embryonic kidney 293T cells. |
| Q37839350 | Cell entry of enveloped viruses. |
| Q33412456 | Computational analysis of the cathepsin B inhibitors activities through LR-MMPBSA binding affinity calculation based on docked complex |
| Q42001497 | Design, synthesis and biological evaluation of a library of thiocarbazates and their activity as cysteine protease inhibitors |
| Q96018100 | High throughput virtual screening reveals SARS-CoV-2 multi-target binding natural compounds to lead instant therapy for COVID-19 treatment |
| Q28833848 | Is It Reliable to Use Common Molecular Docking Methods for Comparing the Binding Affinities of Enantiomer Pairs for Their Protein Target? |
| Q38799069 | Microbial inhibitors of cysteine proteases. |
| Q33974696 | Multi-conformation 3D QSAR study of benzenesulfonyl-pyrazol-ester compounds and their analogs as cathepsin B inhibitors |
| Q33535606 | QSAR models for predicting cathepsin B inhibition by small molecules--continuous and binary QSAR models to classify cathepsin B inhibition activities of small molecules |
| Q39991328 | Self-organizing molecular fingerprints: a ligand-based view on drug-like chemical space and off-target prediction |
| Q33508911 | The identification, characterization and optimization of small molecule probes of cysteine proteases: experiences of the Penn Center for Molecular Discovery with cathepsin B and cathepsin L. |
Search more.